Path from the discovery to the elimination of hepatitis C virus: Honoring the winners of the Nobel Prize in Physiology or Medicine 2020-Reference-Cited by-同舟云学术

Path from the discovery to the elimination of hepatitis C virus: Honoring the winners of the Nobel Prize in Physiology or Medicine 2020

Published:2020-12-18 Issue:1 Volume:37 Page:7-11
ISSN:1607-551X
Container-title:The Kaohsiung Journal of Medical Sciences
language:en
Short-container-title:The Kaohsiung Journal of Medical Sciences

Author:

Yu Ming‐Lung¹²³⁴^ORCID,Chuang Wan‐Long¹²

Affiliation:

1. Hepatobiliary Division, Department of Internal Medicine and Hepatitis Center Kaohsiung Medical University Hospital Kaohsiung Taiwan

2. School of Medicine and Hepatitis Research Center, College of Medicine, and Center for Cancer Research and Center for Liquid Biopsy and Cohort Research Kaohsiung Medical University Kaohsiung Taiwan

3. Institute of Biomedical Sciences National Sun Yat‐Sen University Kaohsiung Taiwan

4. Department of Biological Science and Technology, College of Biological Science and Technology National Chiao Tung University Hsin‐Chu Taiwan

Publisher

Wiley

Subject

General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/kjm2.12345

Reference33 articles.

1. Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study

2. Posttransfusion Hepatitis After Exclusion of Commercial and Hepatitis-B Antigen-Positive Donors

3. Transfusion-Associated Hepatitis Not Due to Viral Hepatitis Type A or B

4. CLINICAL AND SEROLOGICAL ANALYSIS OF TRANSFUSION-ASSOCIATED HEPATITIS

5. TRANSMISSIBLE AGENT IN NON-A, NON-B HEPATITIS

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dual-etiology MAFLD: the interactions between viral hepatitis B, viral hepatitis C, alcohol, and MAFLD;Hepatology International;2024-08-08

2. Metformin and statins reduce hepatocellular carcinoma risk in chronic hepatitis C patients with failed antiviral therapy;Clinical and Molecular Hepatology;2024-07-01

3. Single‐tube, single‐strip lateral flow assays utilizing loop‐mediated isothermal amplification for simultaneous hepatitis B and C viral detection;Journal of Medical Virology;2024-06

4. From nonalcoholic steatohepatitis, metabolic dysfunction-associated fatty liver disease, to steatotic liver disease: Updates of nomenclature and impact on clinical trials;Clinical and Molecular Hepatology;2023-10-01

5. Sharing Lessons Learned to Build Effective Hepatitis Elimination Programs;The Journal of Infectious Diseases;2023-09-13